| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PLIANT THERAPEUTICS, INC. | Chief Operating Officer | Common Stock | 37,806 | $48,391 | $1.28 | 20 Jan 2026 | Direct |
| PLIANT THERAPEUTICS, INC. | Chief Operating Officer | Stock Option (Right to Buy) | 300,000 | 22 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | 22 Jan 2026 | 1 | $0 | 4 | Chief Operating Officer | 26 Jan 2026, 16:36 |
| PLRX | PLIANT THERAPEUTICS, INC. | 20 Jan 2026 | 1 | -$8,854 | 4 | Chief Operating Officer | 22 Jan 2026, 21:38 |
| PLRX | PLIANT THERAPEUTICS, INC. | 10 Dec 2025 | 0 | $0 | 3 | Chief Operating Officer | 22 Dec 2025, 17:02 |